Sandra Visit 2: A 34-Year-Old Woman with Refractory Ulcerative Colitis

Curriculum:
A 28-year-old Woman with Ulcerative Colitis
Credits:
0.5 AMA PRA Category 1 Credits
Launch Date:
28-Dec-10
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No Primary Audience Was Provided.

Relevant Terms:

No Primary Audience Was Provided.

Daniel H. Present, MD

Daniel H. Present, MD
Clinical Professor of Medicine
Division of Gastroenterology
Mount Sinai School of Medicine
Attending Physician
Mount Sinai Hospital
New York, New York

Daniel H. Present, MD, is Clinical Professor of Medicine at Mount Sinai School of Medicine and the creator and donor of an Endowed Clinical Research Fellowship at Mount Sinai Medical Center, New York, New York. He is a board-certified gastroenterologist in private practice, has conducted clinical research for more than 30 years, and is a founder of the Foundation for Clinical Research in Inflammatory Bowel Disease.

Dr. Present is a member of the American Gastroenterological Association and a Master of the American College of Gastroenterology. He has been a member of the National Scientific Advisory Board of the Crohn's and Colitis Foundation of America (CCFA), was Chairperson of its Patient Education Committee, and is a recipient of the CCFA Lifetime Achievement Award. Dr. Present is a recipient of the American Gastroenterological Association's Distinguished Clinician Award; a recipient of the William Dock Master Teaching Award from the State University of New York; and a recipient of the George Arents Award for Lifetime Achievement, Syracuse University's highest alumni honor.

Dr. Present has published more than 150 scientific articles and abstracts on inflammatory bowel disease and its treatment and is co-editor of two books and producer of several educational videotapes. He is a reviewer for major medical journals including Gastroenterology, American Journal of Gastroenterology, and Gut, and past editor of the "Controversy" section of Inflammatory Bowel Diseases. Dr. Present received his medical degree from the State University of New York Downstate Medical Center and was a resident in gastroenterology and internal medicine at Mt. Sinai Medical Center in New York City.

David T. Rubin, MD, AGAF

David T. Rubin, MD, AGAF
Associate Professor of Medicine
University of Chicago Pritzker School of Medicine
Co-Director, Inflammatory Bowel Disease Center
Program Director, Fellowship in Gastroenterology, Hepatology and Nutrition
University of Chicago Medical Center
Chicago, Illinois

David T. Rubin, MD, AGAF, is Associate Professor of Medicine; Director of the Fellowship Program in Gastroenterology, Hepatology, and Nutrition; and Co-Director of the Inflammatory Bowel Disease Center at the University of Chicago Pritzker School of Medicine and the University of Chicago Medical Center, Chicago, Illinois. He is an investigator in the University of Chicago Comprehensive Cancer Center and a member of the Associate Faculty of the University of Chicago MacLean Center for Clinical Medical Ethics. Dr. Rubin's research interests include clinical outcomes in inflammatory bowel disease (IBD), colon cancer screening and prevention, the teaching of medicine, and clinical medical ethics. He is principal investigator of several research projects and clinical trials involving wireless capsule endoscopy in IBD, measures of inflammation and cancer risk, and novel technologies for disease monitoring, and has contributed numerous peer-reviewed publications, book chapters, review articles, and abstracts to the medical literature. He has written a handbook for hospitalized patients with IBD and is co-editor of the textbook Curbside Consultation in IBD: 49 Clinical Questions.
 
Dr. Rubin is a member of the American Gastroenterological Association and serves on its Public Affairs and Advocacy Committee and Subcommittee for Training. He is a fellow of the American College of Gastroenterology and a member of its Professional Issues, Research, and Publications Committees, and a member of the Crohn's & Colitis Foundation of America. He received his medical degree with honors from the University of Chicago Pritzker School of Medicine, where he also completed a residency in internal medicine and fellowships in gastroenterology and clinical medical ethics; he was chief resident and chief fellow in gastroenterology.

Uma Mahadevan, MD

Uma Mahadevan, MD
Associate Professor of Clinical Medicine
University of California, San Francisco
Director of Clinical Research
UCSF Center for Colitis and Crohn's Disease
UCSF Medical Center
San Francisco, California

Uma Mahadevan, MD, is Associate Clinical Professor of Medicine, University of California, San Francisco School of Medicine, and Director of Clinical Research at the UCSF Center for Colitis and Crohn's Disease, UCSF Medical Center, San Francisco, California. Dr. Mahadevan's research interest is inflammatory bowel disease (IBD), particularly as it relates to fertility and pregnancy, new drug trials, and pouchitis. She is interested in the development of novel therapies for IBD and in fertility and pregnancy outcomes in women with IBD, and has published many peer-reviewed articles on these subjects. Dr. Mahadevan received her medical degree from the State University of New York, Brooklyn, and completed a residency in internal medicine at Mount Sinai Medical Center, New York, New York. She was a fellow in gastroenterology at UCSF, and a fellow in IBD at the Mayo Clinic, Rochester, Minnesota.
1. Discuss factors to consider when classifying disease severity and identifying optimal treatment strategies for ulcerative colitis
2. Describe the limitations of clinical guidelines regarding new and emerging pharmacological approaches to treatment
3. Identify patients on conventional therapy who are nonadherent due to poor symptom control
4. Determine the appropriate screening intervals for surveillance of dysplasia